O'Neill R S, Belousova N, Malouf M A
St Vincent's Hospital Department of Lung Transplant, Sydney, NSW, Australia.
Case Rep Transplant. 2019 Jun 16;2019:9431751. doi: 10.1155/2019/9431751. eCollection 2019.
Niemann-Pick Disease (NPD) type B is a rare autosomal recessive disease characterised by hepatosplenomegaly and pulmonary disease, highlighted by preserved volumes and diminished diffusion capacity of the lung for carbon monoxide (DLCO) on pulmonary function tests (PFTs). There is no current accepted treatment for the disease. We present a case of a successful bilateral lung transplant in a patient with a DLCO of 14%, and significant pulmonary changes attributable to NPD type B on computed tomography (CT) chest, and both microscopic and macroscopic assessment of the lung explant. To the author's knowledge this is only the third case of lung transplantation in a patient with NPD type B and is one of two current living patients post lung transplantation for NPD type B.
A 64-year-old male patient underwent bilateral lung transplantation for NPD type B. Preoperative PFTs demonstrated preserved volumes with significantly decreased DLCO, with imaging showing a diffuse reticular interstitial pattern, typical of chronic fibrotic lung disease. The patient suffered from primary graft dysfunction type 3 in the postoperative period as well as rejection managed with methylprednisolone and intravenous immunoglobulin. The patient improved steadily and was discharged 80 days post-transplantation.
This case is only the third reported case of lung transplantation in a patient with NPD type B and the second case of a patient with NPD type B currently living post-transplantation, being at postoperative day (POD) 267 at the time of manuscript drafting. It demonstrates that lung transplantation, although hazardous, is a viable strategy for treatment in patients with NPD type B who have significant pulmonary involvement.
B型尼曼-匹克病(NPD)是一种罕见的常染色体隐性疾病,其特征为肝脾肿大和肺部疾病,肺功能测试(PFT)显示肺容积保留但一氧化碳弥散能力(DLCO)降低。目前尚无针对该疾病的公认治疗方法。我们报告一例成功进行双侧肺移植的病例,该患者DLCO为14%,胸部计算机断层扫描(CT)显示有显著的肺部改变,可归因于B型NPD,同时对肺移植组织进行了微观和宏观评估。据作者所知,这是B型NPD患者进行肺移植的第三例病例,也是目前两名B型NPD肺移植术后存活患者之一。
一名64岁男性患者因B型NPD接受了双侧肺移植。术前肺功能测试显示肺容积保留但DLCO显著降低,影像学显示弥漫性网状间质模式,这是慢性纤维化肺病的典型表现。患者术后出现3型原发性移植功能障碍以及排斥反应,通过甲基强的松龙和静脉注射免疫球蛋白进行处理。患者病情稳步改善,移植术后80天出院。
该病例是B型NPD患者肺移植的第三例报告病例,也是目前B型NPD肺移植术后存活患者的第二例,撰写本文时处于术后第267天。这表明肺移植尽管有风险,但对于有严重肺部受累的B型NPD患者来说是一种可行的治疗策略。